Thieme E-Books & E-Journals -
Zurück
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2023; 20(02): e6-e7
DOI: 10.1055/s-0043-1769141
Abstracts | DGS

EMBER-4: a Phase 3 adjuvant trial of imlunestrant vs standard endocrine therapy in patients with ER+, HER2− early breast cancer with an increased risk of recurrence who have previously received 2 to 5 years of adjuvant ET

N. Harbeck
1   Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Hospital, München, Deutschland
,
K. Jhaveri
2   Memorial Sloan Kettering Cancer Center, New York, Vereinigte Staaten
,
J. O'Shaughnessy
3   Medical Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Vereinigte Staaten
,
F. Andre
4   Gustave Roussy, Universite Paris Saclay, INSERM, Villejuif, Frankreich
,
M. P. Goetz
5   Mayo Clinic, Department of Oncology, Rochester, Vereinigte Staaten
,
M. Martin
6   Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spanien
,
F.-C. Bidard
7   Institute Curie, UVSQ and Paris-Saclay University, Department of Medical Oncology, Saint-Cloud, Frankreich
,
Z. M. Thomas
8   Eli Lilly and Company, Indianapolis, Vereinigte Staaten
,
S. R. Young
9   LOXO@Lilly, Lilly Corporate Center, Indianapolis, Vereinigte Staaten
,
R. Ismail-Khan
9   LOXO@Lilly, Lilly Corporate Center, Indianapolis, Vereinigte Staaten
,
L. M. Smyth
9   LOXO@Lilly, Lilly Corporate Center, Indianapolis, Vereinigte Staaten
,
M. Gnant
10   Comprehensive Cancer Center, Medical University of Vienna, Wien, Österreich
› Institutsangaben